Scientists at CNIO support new manager accused of harassment and denounce a campaign of discredit
Scientists at the CNIO have voiced their support for José Manuel Bernabé, the new manager facing harassment allegations, claiming that he is a target of a discrediting campaign related to his investigations into corruption.
The CNIO manager accused of harassment had reported dozens of corrupt practices, including a tailored contract for the 'harassed'
José Manuel Bernabé, manager of the CNIO, faces allegations of sexual harassment while also uncovering corrupt practices linked to his predecessor and others.
Science will request the dismissal of the manager of the CNIO, accused of harassment by the former general secretary
The Ministry of Science in Spain is set to request the dismissal of José Manuel Bernabé, the manager of the CNIO, following allegations of harassment by a former official.
The Ministry of Science requests the dismissal of the manager of the CNIO after 'an alleged case of harassment'
Spain's Ministry of Science has requested the dismissal of José Manuel Bernabé, manager of the National Cancer Research Centre (CNIO), following allegations of harassment against former secretary general Laura Muñoz.
The CNIO fired the senior executive who reported alleged favoritism towards Barbacid with two patents
The CNIO terminated the employment of Roke Oruezabal after he reported potential favoritism in the allocation of patents to Mariano Barbacid.
The CNIO ruled out the patent as 'too weak' with which Barbacid has already raised 3.5 million against pancreatic cancer
The CNIO dismissed a patent related to pancreatic cancer treatment proposed by scientist Mariano Barbacid, citing insufficient novelty and inventive activity.
Sanction against CNIO for dismissing whistleblowers to whom the Ministry of Science didn't even respond
The Independent Authority for Whistleblower Protection has initiated sanctions against CNIO for retaliating against whistleblowers who reported corruption, including a 25 million euro embezzlement allegation.
The True Story Behind 'The First Effective Therapy Against Pancreatic Cancer' by Mariano Barbacid
Mariano Barbacid's company Vega Oncotargets has toned down its slogan after generating false expectations from a promising experiment involving 45 'cured' mice, prompting over a hundred pancreatic cancer patients to seek assistance from the CNIO.
Concern over the expectations created by Barbacid about pancreatic cancer: 'The announcement has gotten out of hand'
The National Center for Cancer Research (CNIO) has seen an unprecedented number of inquiries following Mariano Barbacid's announcement of successfully eliminating a type of pancreatic cancer in mice using a combination of three drugs.
CNIO Researchers Eliminate Pancreatic Cancer in Mice for the First Time Without Resistance Appearing
Researchers at the CNIO have successfully eliminated the most common form of pancreatic cancer in mice, using a combination therapy that prevents resistance and has no major side effects.
The CNIO closes its cancer drug development and diagnostic units
The National Center for Cancer Research (CNIO) has shut down its cancer diagnosis and drug development units while launching a new action plan focusing on artificial intelligence and computational methodologies.
The new action plan of the CNIO includes the closure of cancer diagnosis units and the development of new drugs
The new phase of the National Center for Cancer Research (CNIO) involves closing cancer diagnosis units and focusing on the development of new drugs to enhance oncological research.
The CNIO closes its cancer diagnosis and new drug development units
The National Cancer Research Center (CNIO) will close three scientific units, impacting over 20 employees amid an unprecedented crisis.
CNIO researchers discover two new genes that predispose to pancreatic cancer
Researchers from the CNIO have identified two new genes associated with an increased risk of developing pancreatic cancer, specifically the most common and least survivable type.